Key result
Home monitoring of oral anticoagulation in paediatric patients yielded no thrombotic or haemorrhagic complications over 44.7 patient-years, with a median 69% of INR values in the therapeutic range.
Why the study?
Is home monitoring of oral anticoagulant treatment with CoaguChek feasible and safe in paediatric patients?
Observational (n=19)
Is home monitoring of oral anticoagulant treatment with CoaguChek feasible and safe in paediatric patients?
Home monitoring of oral anticoagulant treatment in pediatric patients is feasible, safe, and generally well-accepted by families, though professional supervision remains crucial.
Supports feasibility of home monitoring in this small paediatric cohort; leaves open safety confirmation in larger randomized trials.
AIM: To evaluate the feasibility of home monitoring of oral anticoagulant treatment (OAT) in paediatric patients. METHODS: A total of 19 paediatric patients received OAT and then monitored their treatment at home with CoaguChek. Data on their International Normalized Ratio (INR) values were collected retrospectively from hospital records and from the notes kept by the families. The families of the patients were also asked to fill in a questionnaire. RESULTS: No thrombotic or haemorrhagic complications occurred during a total amount of 44.7 follow-up years. INR: the proportion of INR values measured at home falling within the therapeutic range for the given patient varied from 33 to 86% (median 69%). The questionnaire: all respondents were satisfied with home monitoring, and 63% felt that a major advantage of home monitoring was that there was no need to perform venipuncture. While 47% of the respondents reported no disadvantages of home monitoring, 42% reported that they occasionally lacked confidence in their ability to conduct OAT correctly at home. CONCLUSION: Home monitoring of OAT is feasible and reasonably reliable in paediatric patients. However, it is crucial that healthcare professionals supervise the treatment and the families are provided with detailed and precise instructions on how to act in a variety of clinical situations.
No takes yet. Share an insight, caveat, or question.
Mähönen et al. (2004) conducted an observational in Paediatric patients requiring oral anticoagulant treatment (n=19). Home monitoring of oral anticoagulant treatment with CoaguChek was evaluated on Thrombotic or haemorrhagic complications. Home monitoring of oral anticoagulation in paediatric patients yielded no thrombotic or haemorrhagic complications over 44.7 patient-years, with a median 69% of INR values in the therapeutic range.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: